02 July 2004
Too much lumping in ischemic stroke – a new classification
Michael Hoffmann, Rossitza Chichkova, Mafhoud Ziyad, Ali MalekMed Sci Monit 2004; 10(7): CR285-287 :: ID: 11702
Abstract
Background:The heterogeneity of ischemic stroke syndromes with treatment of disparate categories may be a factor in clinical stroke trial failure. Recent advances include a multitude of stroke investigative modalities that are noninvasive, allowing more precise mechanistic determination.Material/Methods:We retrospectively analyzed our young stroke patient population for stroke etiology according to the TOAST classification with five different etiological groups. Patients were assessed quantitatively according to the National Institute of Health Stroke Scale for neurological deficit and Rankin Scale for neurological handicap. Investigations included laboratory, Doppler sonograms of the cervicocephalic vessels, cardiac echocardiography and multimodality magnetic resonance imaging in all patients. Statistical analysis was performed, using a logit model for nominal response: log πj/πJ)=alphaj+βjX.Results:Amongst young stroke patients (n=133, women n=72) causes included other (n=77/119;65%), large vessel disease (LVD) (n=8/119;7%), small vessel disease (SVD) (n=17/119;14%), unknown (n=3/119;2%) and cardiac (n=14/119;12%). Within the other category at least 20 different etiologies were delineated. There were significant differences among the various categories (multinomial distribution with equal probabilities p=<0.0001).
Conclusions: We recommend an expanded classification for stroke to include large vessel cerebrovascular disease, small vessel cerebrovascular disease, cardiogenic, dissection, prothrombotic states, migraine induced, cerebral venous thrombosis, vasculitides, vasculopathy other, miscellaneous and unknown.
Keywords: Cerebrovascular Accident - diagnosis, Adolescent, Brain Ischemia - etiology, Cerebral Infarction - etiology, Clinical Trials as Topic, Cohort Studies, Regression Analysis, Severity of Illness Index, Stroke - etiology
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952